article
Scientists demonstrate how disrupting the Cx26 molecular complex in triple-negative…
25 January 2024 | By Ellen Capon (Drug Target Review)
Scientists demonstrate how disrupting the Cx26 molecular complex in triple-negative breast cancer cells slowed tumour growth.